Clinical Trial Update: ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing aliskiren and losartan evaluated biomarkers of myocardial remodeling in patients with hypertension and left ventricular hypertrophy; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Cozaar (losartan)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension, Left Ventricle Hypertrophy | Phase 4 | Status: COMPLETED | Results posted: 2014-07-24